A Study of Belzutifan (MK-6482) in Participants With Hepatic Impairment (MK-6482-020)

Clinical trial NCT04995484 · COMPLETED

Trial details

NCT number: NCT04995484
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate Hepatic Impairment

Start date: 2022-06-24
Primary completion: 2023-12-25
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.